Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Yutaka, Takahara"'
Autor:
Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa
Publikováno v:
Thoracic Cancer, Vol 15, Iss 12, Pp 987-993 (2024)
Abstract Background Pemetrexed (PEM) is the primary chemotherapy for non‐small cell lung cancer (NSCLC), showing potential for long‐term disease stability in certain cases. However, studies examining disease control with PEM therapy are lacking.
Externí odkaz:
https://doaj.org/article/6fc1ea41a0b142279a109622e0964639
Autor:
Yutaka Takahara, Sumito Nagae, Aika Yamagata, Yoshihito Iijima, Akihiro Shioya, Sohsuke Yamada, Hidetaka Uramoto
Publikováno v:
Thoracic Cancer, Vol 15, Iss 12, Pp 1034-1037 (2024)
Abstract Lung cancer complicated by follicular lymphoma has rarely been reported in the literature. A 69‐year‐old male with an abnormal shadow on a chest radiograph was referred to our hospital. A mass in the right lung was seen on chest computed
Externí odkaz:
https://doaj.org/article/80969fd53eb04b409232bbf5914d15ac
Autor:
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa
Publikováno v:
Thoracic Cancer, Vol 14, Iss 36, Pp 3549-3555 (2023)
Abstract Background Several options for second‐line therapy are available for patients with advanced non‐small cell lung cancer (NSCLC); however, the optimal therapy remains unclear. Docetaxel (DTX) monotherapy and DTX plus ramucirumab (RAM) are
Externí odkaz:
https://doaj.org/article/3dfcc8af26d449629347ab88334f53e4
Autor:
Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa
Publikováno v:
Thoracic Cancer, Vol 14, Iss 27, Pp 2754-2760 (2023)
Abstract Background Immune checkpoint inhibitor (ICI) monotherapy is currently approved for the treatment of advanced non‐small cell lung cancer (NSCLC) patients with programmed death ligand‐1 (PD‐L1) expression ≥50%. However, the efficacy of
Externí odkaz:
https://doaj.org/article/a909f4025c2145fc8914aa045dfc6961
Autor:
Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno
Publikováno v:
Thoracic Cancer, Vol 14, Iss 14, Pp 1286-1293 (2023)
Abstract Background Amrubicin (AMR) has become the standard of care for post‐relapse small cell lung cancer (SCLC). It has also been reported to achieve long‐term disease control in patients with good treatment response. However, the optimal pati
Externí odkaz:
https://doaj.org/article/99ed1c0dd4b14c28b5532ac4338190f1
Autor:
Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno
Publikováno v:
Thoracic Cancer, Vol 13, Iss 24, Pp 3451-3458 (2022)
Abstract Background The clinical characteristics and risk factors for cancer recurrence have not been well evaluated regarding early recurrence in patients with unresectable locally advanced non‐small cell lung cancer (LA‐NSCLC) who receive concu
Externí odkaz:
https://doaj.org/article/bdb7c18e454343c4adf578a932fafbac
Autor:
Hirofumi Nagai, Tsutomu Shimada, Yoshimitsu Takahashi, Mikako Nishikawa, Hiroyuki Tozuka, Yasuto Yamamoto, Osamu Niwa, Yutaka Takahara, Arimi Fujita, Katsuhiko Nagase, Kazuo Kasahara, Seiji Yano, Yoshimichi Sai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract Background Gefitinib and erlotinib, are epidermal growth factor receptor tyrosine kinase inhibitors, and are currently recommended for non-small cell lung cancer stage IV in the elderly and in patients with decreased performance status in th
Externí odkaz:
https://doaj.org/article/0079c9a575984d6282c483eb99d3b786
Autor:
Shohei Shinomiya, Takuya Tanaka, Ikuyo Shionoya, Tatsuki Mura, Keisuke Nakase, Yutaka Takahara, Taku Oikawa, Shiro Mizuno
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Legionella longbeachae is a Legionella bacteria often detected in soil, and is known as a rare cause of Legionella infections in Japan. In addition, detection of this Legionella species is often overlooked due to negative results from Legionella urin
Externí odkaz:
https://doaj.org/article/64901bf2455f4b608ee5b797d534758f
Publikováno v:
Sleep Medicine Research, Vol 13, Iss 1, Pp 15-21 (2022)
Background and Objective Decreased ventilatory response to carbon dioxide or hypercapnic ventilatory response (HCVR) is a feature of pediatric obstructive sleep apnea (OSA) and is also known to diminish during sleep in obese adolescents (age, 12–16
Externí odkaz:
https://doaj.org/article/7d78c2087bf54f46b83d2e50fc2c496a
Autor:
Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno
Publikováno v:
Thoracic Cancer, Vol 13, Iss 4, Pp 624-630 (2022)
Abstract Background The efficacy of rechallenge with immune checkpoint inhibitors (ICIs) in non‐small cell lung cancer (NSCLC) patients has not yet been fully clarified. This study aimed to identify the clinical characteristics of patients with NSC
Externí odkaz:
https://doaj.org/article/067210945ff64d138e15835a689a5cea